Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

587
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
587
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

354
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

143
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
143
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

371
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
371
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

337
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
337
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.4K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of GSMaP and MSWEP precipitation products for runoff simulation in the Lhasa River Basin.

PloS one·2026
Same author

The RPA-binding domain and the KKRK motif in Rad26ATRIP cooperate at the perturbed DNA replication fork for initiating checkpoint signalling.

PLoS genetics·2026
Same author

cAMP-enriched extracellular vesicles improve outcomes in pulmonary hypertension.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Effect of frequency side channels on the security of practical quantum key distribution.

Optics express·2025
Same author

Development and Validation of Clinical Practice Standards for Physical Restraint in Hospitalized Patients: A Multi-Method Study.

Journal of multidisciplinary healthcare·2025
Same author

Contrasting Lifestyle of Free-Living and Particle-Attached Microbes Shaped Community Dynamics and Stability in the Seamount Environment.

Molecular ecology·2025

Related Experiment Video

Updated: May 5, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

39.6K

Different cardiovascular risks associated with elevated creatinine-based eGFR and cystatin C-based eGFR.

Mengyi Liu1, Ziliang Ye1, Panpan He1

  • 1Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, 510515, Guangzhou, China.

NPJ Cardiovascular Health
|March 3, 2026
PubMed
Summary

Elevated kidney function markers show differing cardiovascular risks. High creatinine-based eGFR (eGFRcr) increases cardiovascular disease (CVD) risk, while high cystatin C-based eGFR (eGFRcys) lowers it. Both reduce chronic kidney disease (CKD) risk.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.5K

Related Experiment Videos

Last Updated: May 5, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
09:09

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice

Published on: August 9, 2013

39.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.5K

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Estimated glomerular filtration rate (eGFR) is crucial for assessing kidney function.
  • Two common markers, creatinine (eGFRcr) and cystatin C (eGFRcys), are used to estimate eGFR.
  • The association of elevated eGFR with cardiovascular disease (CVD) and chronic kidney disease (CKD) risk requires further clarification.

Purpose of the Study:

  • To compare the association of elevated eGFRcr and eGFRcys with the risk of incident CVD and CKD.
  • To investigate differential risks associated with high kidney function estimates based on creatinine versus cystatin C.

Main Methods:

  • A cohort study of 372,060 participants from the UK Biobank, initially free of CVD and CKD.
  • Participants categorized into low, normal, and high eGFR groups based on age- and sex-specific percentiles.
  • Primary outcome: incident CVD (ischemic heart disease, stroke, heart failure, atrial fibrillation) over a median 12.4-year follow-up.

Main Results:

  • High eGFRcr was associated with a significantly higher risk of CVD (HR, 1.19).
  • High eGFRcys was associated with a significantly lower risk of CVD (HR, 0.90).
  • Both high eGFRcr and high eGFRcys were associated with a lower risk of CKD.

Conclusions:

  • Elevated eGFRcr is linked to increased CVD risk, contrasting with eGFRcys which is linked to decreased CVD risk.
  • Both markers of elevated kidney function are associated with a reduced risk of developing CKD.
  • These findings highlight the importance of the eGFR estimation method in risk assessment for CVD and CKD.